Clinical Trial Update: Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

View source ↗

Summary

Bayer-sponsored clinical trial in Japan evaluating caregiver burden in patients with wet age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Snippet

Sponsor: Bayer | Conditions: Wet Macular Degeneration | Status: COMPLETED